Univ. Lille, INSERM, CNRS, CHU Lille, Institut Pasteur de Lille, U1283-UMR8199-EGID, F-59000 Lille, France.
Faculté de Médecine, CNRS, INSERM, iBV, Université Côte d'Azur, CEDEX 2, F-06107 Nice, France.
Cells. 2023 Mar 10;12(6):870. doi: 10.3390/cells12060870.
Human induced pluripotent stem cells (hiPSCs) have the potential to be differentiated into any cell type, making them a relevant tool for therapeutic purposes such as cell-based therapies. In particular, they show great promise for obesity treatment as they represent an unlimited source of brown/beige adipose progenitors (hiPSC-BAPs). However, the low brown/beige adipocyte differentiation potential in 2D cultures represents a strong limitation for clinical use. In adipose tissue, besides its cell cycle regulator functions, the cyclin-dependent kinase inhibitor 2A () locus modulates the commitment of stem cells to the brown-like type fate, mature adipocyte energy metabolism and the browning of adipose tissue. Here, using a new method of hiPSC-BAPs 3D culture, via the formation of an organoid-like structure, we silenced expression during hiPSC-BAP adipogenic differentiation and observed that knocking down potentiates adipogenesis, oxidative metabolism and the browning process, resulting in brown-like adipocytes by promoting UCP1 expression and beiging markers. Our results suggest that modulating levels could be relevant for hiPSC-BAPs cell-based therapies.
人类诱导多能干细胞(hiPSCs)具有分化为任何细胞类型的潜力,使其成为治疗目的的相关工具,例如基于细胞的治疗。特别是,它们在肥胖治疗方面显示出巨大的潜力,因为它们代表了棕色/米色脂肪祖细胞(hiPSC-BAPs)的无限来源。然而,2D 培养物中低的棕色/米色脂肪细胞分化潜力代表了临床应用的一个强烈限制。在脂肪组织中,除了其细胞周期调节剂功能外,周期蛋白依赖性激酶抑制剂 2A()基因座调节干细胞向棕色样命运、成熟脂肪细胞能量代谢和脂肪组织褐变的定向分化。在这里,我们使用一种新的 hiPSC-BAPs 3D 培养方法,通过形成类器官样结构,在 hiPSC-BAP 成脂分化过程中沉默 表达,并观察到敲低 可增强脂肪生成、氧化代谢和褐变过程,通过促进 UCP1 表达和 beige 标志物来产生棕色样脂肪细胞。我们的结果表明,调节 水平可能与基于 hiPSC-BAPs 的细胞治疗相关。